Loading organizations...
§ Private Profile · Toronto, ON, Canada
AI-native SaaS platform automating administrative and clinical workflows for pharmacies, focusing on prescription processing and medication reviews.
Based in Toronto, Ontario, Asepha develops an artificial intelligence platform that automates administrative and clinical workflows for retail pharmacies and healthcare enterprises. The enterprise software functions as an AI copilot, utilizing agentic tools and optical character recognition to process handwritten prescriptions, screen phone calls, conduct medication reviews, and generate comprehensive patient profiles. Operating as a business-to-business software provider with an estimated team of fewer than 10 employees, the healthcare technology company recently secured a $4 million seed funding round to double its staff and open a New York office in the United States. The startup currently serves several undisclosed Fortune 50 enterprise customers and is backed by prominent venture capital investors including Y Combinator, Glasswing Ventures, Core Innovation Capital, and Ripple Ventures. Asepha was officially founded in 2023 by co-founders Eunice Wu and Can Uncu.
Asepha has raised $4.0M across 1 funding round.
Asepha has raised $4.0M in total across 1 funding round.
Asepha has raised $4.0M in total across 1 funding round.
Asepha's investors include Edwin Loredo, Front Row Round, MGV, Panache Ventures, Redbud VC, Ripple Ventures.
Asepha has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in July 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 14, 2025 | $4M Seed | Edwin Loredo | Front ROW Round, MGV, Panache Ventures, Redbud VC, Ripple Ventures | Announced |